READ-ONLY DIGITIZATION RESULT
Safety and efficacy of repeat ivermectin mass drug administrations for malaria control (RIMDAMAL II): a phase 3, double-blind, placebo-controlled, cluster-randomised, parallel-group trial.
Lancet Infect Dis · 2025-Jul · PMID 39919778
Panel An._gambiae_s.l._2019_3_weeks_post-MDA提取完成待 EXE 对齐验证
survival
Mosquito survivorship post-MDA by mosquito species Survival of wild-type, naturally blood fed mosquitoes aspirated from 3 pre-selected clusters per arm, one week and three weeks following the start of each MDA. Black and red lines are from control group and intervention group mosquitoes, respectively.
算法:legacy-0.5.0引擎:enhanced-linux
曲线数据
网页最多预览 200 行,完整数据请下载 CSV 或 JSON。
当前面板没有可预览的 `curves_mapped.csv` 数据。
历史版本(1)
重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。
| 版本 | 状态 | 验证 | 曲线 | 时间 |
|---|---|---|---|---|
| legacy-0.5.0 | complete | 待验证 | 2 | 2026-07-18T20:09:49+00:00 |